SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Mirror Image11/16/2015 12:41:19 PM
   of 2026
 
As of this minute not all Institutions have reported their holdings in Apricus Bio for the 3Q 2015.
I was waiting for Sarissa Capital Management and Healthcare Value Capital to update their holdings before I posted a final number. Healthcare Value Capital just updated their holdings and did not buy/sell any shares - so they remain at 650,000 shares as of September 30, 2015.

What Healthcare Value Capital did do during the 3Q 2015 is buy a 100,000 CALL position in Apricus.

With the institutions that have updated their holdings - the Quarter is looking like another one where more Shares have been going from retail hands into Institutional holdings. We should know the final number in a couple days.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News